Drug intelligence / Profile preview

lycopene + soy isoflavone

Development stage
Unknown
Lead developer
CamMedica
Modality
Small Molecules
Administration
Oral
01

Overview

Lycopene + soy isoflavone is a combination dietary supplement investigated for its potential benefits in metabolic health and glucose regulation. Lycopene is a potent antioxidant carotenoid primarily derived from tomatoes, while soy isoflavones (such as genistein and daidzein) are phytoestrogens known to modulate lipid and glucose metabolism. The specific formulation Laflavon, developed by CamMedica, is designed to enhance the bioavailability of these components, containing 7 mg of lycopene and 50 mg of soy isoflavones. Clinical research, including trials sponsored by the University of Texas Medical Branch, has focused on the combination's ability to improve glucose tolerance, reduce insulin resistance, and lower HbA1c levels in patients with metabolic syndrome or mild Type 2 diabetes mellitus.

Brand names
Laflavon
Other names
lycopene and isoflavoneslycopene + isoflavones
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on lycopene + soy isoflavone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lycopene + soy isoflavone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call